Comparison of Nausea and Vomiting in Patients Receiving Dexamethasone With Intravenous Methocloperamide Under Bronchoscopy with Total Intravenous Anesthesia


Authors : Abdillah Habib; Achsanuddin Hanafie; Akhyar H. Nasution

Volume/Issue : Volume 7 - 2022, Issue 1 - January

Google Scholar : http://bitly.ws/gu88

Scribd : https://bit.ly/3g5nhy3

DOI : https://doi.org/10.5281/zenodo.5913577

Anesthesiaandbronchoscopyprosedures are associated with postoperative symptoms that cause patient dissatisfaction with anesthesia. The most common symptoms include pain, nausea and vomiting, it is not uncommon for nausea and vomiting to occur on an outpatient basic which will eventually delay the patienat's return from the hospital and leave.Methods:This study was followed by 26 patients using a double-blind randomized method, ASA 1 to 4, which were dividedinto 2 group of 13 patients in eachgroup. Group A. was given dexamethasone 5mg intravenously while group B was given. metoclopramide 10. intravenously.Results: The incidence of PONV in the administration of Dexamethasone 5mg/iv after bronchoscopy was 1 person (7.7%) during the first 24 hours. While giving metoclopramide 10mg/iv were 3 people (23.0%) at the 0th hour, 3 people (23.0%) at the 2nd hour, 3 people (23.0) at the 4th hour, and 2 people (15.3%) at 8thhour. At 24 hours, therewasno PONV incident. Conclusion: The administration of 5 mg dexamethasone showed significant impact in order to decrease the PONV incidence towards the patients who undergo bronchoscopy with total intravenous

Keywords : nausea andvomiting, bronchoscopy, deksametasone, metokloperamide

CALL FOR PAPERS


Paper Submission Last Date
30 - April - 2024

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.
Subscribe
OR

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.
Subscribe